ATN 021a Medical and Health History Form: Coronary Heart Disease [CRF 3] Dataset in Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women

Data from Medical and Health History Form: Coronary Heart Disease [CRF 3]
Study Description
A cross-sectional study that enrolled adolescent and young women, ages 12 through 24, to evaluate the prevalence and severity of morphologic and metabolic abnormalities and to assess the drug and non-drug factors related to these abnormalities. The study assessed differences in glucose metabolism, lipids, lactate, body composition, and bone density between HIV infected and uninfected young women to understand the pathophysiological effects of protease inhibitor (PI)- and non-nucleoside analogue reverse transcriptase inhibitor (NNRTI)-based therapies in young females. One study visit conducted over 1 or more days included survey questionnaires, DEXA scanning, anthropometric measurements, and blood tests examining lactate, glucose, and lipid metabolism. Biospecimens are available.
HIV infected and uninfected females, ages 12 to 24

医学与健康史表单数据：冠心病[病例报告表3（CRF 3）]
研究描述
本研究为横断面研究，纳入年龄12至24岁的青春期及年轻女性人群，旨在评估形态学与代谢异常的患病率及严重程度，并分析与这类异常相关的药物及非药物影响因素。本研究对比人类免疫缺陷病毒（HIV）感染者与未感染年轻女性的糖代谢、血脂、乳酸、身体成分及骨密度差异，以明确以蛋白酶抑制剂（PI）和非核苷类逆转录酶抑制剂（NNRTI）为基础的治疗方案对年轻女性的病理生理影响。单次研究随访为期1天或多天，内容涵盖问卷调查、双能X线吸收测定法（DEXA）扫描、人体测量学指标检测以及针对乳酸、葡萄糖与脂质代谢的血液检验项目。可提供生物样本。
研究对象：年龄12至24岁的HIV感染者与未感染女性。